Table 1.
Patients’ clinical and pathological characteristics. ECOG, Eastern Cooperative Oncology Group; CHT, chemotherapy.
| Characteristics | Enrolled Patients (n = 23) | % |
|---|---|---|
| Gender | ||
| Male | 7 | 30.4% |
| Female | 16 | 69.6% |
| Median age, years | 60.2 | Range 42–79 |
| ECOG performance status | ||
| 0 | 19 | 82.6% |
| 1 | 4 | 17.4% |
| Primitive cancer | ||
| Colorectal | 16 | 69.6% |
| Breast | 2 | 8.7% |
| Ovarian | 5 | 21.7% |
| Stage at study entry | ||
| III | 1 | 4.3% |
| IV | 22 | 95.7% |
| Site of metastases | ||
| Liver | 13 | 56.5% |
| Lung | 7 | 30.4% |
| Lymph nodes | 8 | 34.8% |
| Peritoneal Carcinosis | 4 | 17.4% |
| Bone | 5 | 21.7% |
| Ovary | 1 | 4.3% |
| Adrenal gland | 1 | 4.3% |
| Spleen | 1 | 4.3% |
| No. of involved site for pts | ||
| 1 | 12 | 52.2% |
| 2 | 6 | 26.1% |
| 3 | 5 | 21.7% |
| Previous CHT lines | ||
| yes | 14 | 60.9% |
| no | 9 | 39.1% |